|
|
|
Insider
Information: |
Boyd Steven |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
18 |
|
Direct
Shares |
47,075,098 |
|
Indirect Shares
|
40,287,245 |
|
|
Direct
Value |
$124,670,210 |
|
|
Indirect Value
|
$39,932,089 |
|
|
Total
Shares |
87,362,343 |
|
|
Total
Value |
$164,602,299 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
99
|
96
|
Stock
price went up :
|
54
|
46
|
Stock
price went down : |
45
|
50
|
|
|
|
Gain/Loss Ratio : |
1.2
|
1.2
|
Percentage
Gain/Loss : |
-16.7%
|
8,928.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2023-06-27 |
34,370 |
2023-06-27 |
731,458 |
Premium* |
|
Dynatronics Corp |
DYNT |
10% Owner |
2017-03-21 |
500,000 |
2017-03-21 |
1,000,000 |
Premium* |
|
Kiora Pharmaceuticals |
KPRX |
10% Owner |
2021-01-06 |
3,346,601 |
2021-08-02 |
785,000 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
10% Owner |
2019-01-10 |
2,170,000 |
2019-01-10 |
2,170,000 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2018-02-06 |
6,936,000 |
2018-02-06 |
6,936,000 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2018-10-03 |
1,651,340 |
2018-10-03 |
0 |
Premium* |
|
Del Friscos Restaurant Group, Llc |
DFRG |
10% Owner |
2019-09-25 |
0 |
2019-09-25 |
0 |
Premium* |
|
Valeritas Holdings Inc |
VLRX |
10% Owner |
2019-12-20 |
0 |
2019-12-20 |
0 |
Premium* |
|
Bio-Path Holdings, Inc. |
BPTH |
10% Owner |
2019-01-18 |
129,298 |
2019-01-18 |
129,298 |
Premium* |
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-03-29 |
1,342,378 |
2021-03-29 |
1,342,378 |
Premium* |
|
Achieve Life Sciences Inc |
ACHV |
10% Owner |
2019-06-11 |
843,776 |
2019-06-11 |
843,776 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2020-03-16 |
4,120,000 |
2020-03-16 |
348,000 |
Premium* |
|
Onconova Therapeutics, Inc. |
ONTX |
10% Owner |
2019-09-23 |
816,702 |
2019-09-23 |
816,702 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2020-06-29 |
145,523 |
2020-06-29 |
145,523 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director, 10% Owner |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
Tenax Therapeutics Inc |
TENX |
Director, 10% Owner |
2020-09-08 |
2,019,995 |
2020-09-08 |
2,019,995 |
Premium* |
|
Cyclo Therapeutics, Inc |
CYTH |
10% Owner |
2020-09-30 |
15,795,769 |
2020-09-30 |
15,795,769 |
Premium* |
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2021-06-28 |
7,223,346 |
2021-06-28 |
7,223,346 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
790 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 22 of 32
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-06-07 |
4 |
B |
$4.85 |
$48,750 |
I/I |
10,000 |
300,000 |
2.25 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-12-03 |
4 |
B |
$2.44 |
$48,800 |
D/D |
20,000 |
30,134,285 |
3.92 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-01-11 |
4 |
B |
$3.88 |
$49,313 |
I/I |
12,651 |
18,169,799 |
2.25 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2018-11-21 |
4 |
B |
$0.38 |
$49,729 |
D/D |
130,000 |
19,130,000 |
2.37 |
- |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-03 |
4 |
B |
$1.39 |
$50,040 |
D/D |
36,000 |
1,987,995 |
3.92 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2018-11-20 |
4 |
B |
$3.61 |
$50,512 |
D/D |
14,000 |
17,850,000 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-05-18 |
4 |
B |
$2.33 |
$51,260 |
D/D |
22,000 |
39,100,000 |
3.92 |
% |
|
KPRX |
Kiora Pharmaceuticals |
10% Owner |
|
2018-05-09 |
4 |
B |
$0.50 |
$51,571 |
D/D |
103,953 |
16,653,683 |
2.45 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2017-05-01 |
4 |
B |
$0.50 |
$52,810 |
D/D |
105,620 |
2,901,334 |
2.45 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2018-11-27 |
4 |
B |
$0.36 |
$53,850 |
D/D |
150,000 |
19,500,000 |
2.45 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-03-18 |
4 |
B |
$1.91 |
$54,307 |
I/I |
28,433 |
703,433 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-03-27 |
4 |
B |
$5.48 |
$54,800 |
D/D |
10,000 |
18,304,285 |
3.92 |
- |
|
KPRX |
Kiora Pharmaceuticals |
Director |
|
2018-11-15 |
4 |
B |
$0.43 |
$55,003 |
D/D |
126,735 |
16,984,364 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-08-29 |
4 |
B |
$3.21 |
$55,125 |
D/D |
17,173 |
18,458,642 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-03-26 |
4 |
B |
$0.00 |
$55,200 |
I/I |
10,000 |
290,000 |
2.25 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-08-18 |
4 |
B |
$2.78 |
$55,550 |
I/I |
20,000 |
39,300,000 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2018-12-06 |
4 |
B |
$3.44 |
$56,494 |
D/D |
16,400 |
18,020,000 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-05-24 |
4 |
B |
$5.01 |
$57,114 |
D/D |
11,400 |
18,359,785 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2018-06-28 |
4 |
B |
$4.03 |
$58,482 |
D/D |
14,400 |
16,414,400 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2018-11-13 |
4 |
B |
$3.90 |
$59,645 |
D/D |
15,287 |
17,784,873 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2022-01-12 |
4 |
B |
$1.04 |
$59,781 |
I/I |
57,300 |
45,702,300 |
2.25 |
% |
|
DFRG |
Del Friscos Restaurant Gr... |
10% Owner |
|
2019-01-07 |
4 |
B |
$7.69 |
$60,768 |
I/I |
7,900 |
4,583,900 |
1.5 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-05-13 |
4 |
B |
$4.85 |
$61,047 |
D/D |
12,587 |
18,319,376 |
3.92 |
- |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2019-05-21 |
4 |
B |
$3.82 |
$61,120 |
D/D |
16,000 |
1,036,000 |
2.45 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2018-11-29 |
4 |
B |
$3.48 |
$61,946 |
D/D |
17,803 |
17,977,803 |
2.45 |
- |
|
790 Records found
|
|
Page 22 of 32 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|